Continuing Education
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DIA. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Postgraduate Institute for Medicine designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 3.25 contact hours.
California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 3.25 contact hours.
DIA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for up to 3.25 contact hours or .325 continuing education units (CEUs).Type of Activity: Knowledge 0286-0000-20-064-L04-P
Drug Information Association (DIA) is accredited by the International Association for Continuing Education and Training (IACET) and is authorized to issue the IACET CEU.
As an IACET Accredited Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer .3 CEUs for this program.
Participants must attend the entire program in order to be able to receive an IACET statement of credit. No partial credit will be awarded.
To view DIA’s Grievance Policy, visit DIAglobal.org/CE
| Name | Credit Type | Max Credits | CEU |
| #19:Core Labeling | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #19:Core Labeling | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #19:Core Labeling | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #19:Core Labeling | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #21: Real World Evidence | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #21: Real World Evidence | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #21: Real World Evidence | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #21: Real World Evidence | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #22: Data Visualization in the Life Sciences | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #22: Data Visualization in the Life Sciences | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #22: Data Visualization in the Life Sciences | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #22: Data Visualization in the Life Sciences | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #23: Protocol Co-Design with Patients and Advocate | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #23: Protocol Co-Design with Patients and Advocate | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #23: Protocol Co-Design with Patients and Advocate | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #23: Protocol Co-Design with Patients and Advocate | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #24: Implementing a Risk-Based Monitoring Solution | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #24: Implementing a Risk-Based Monitoring Solution | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #24: Implementing a Risk-Based Monitoring Solution | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #24: Implementing a Risk-Based Monitoring Solution | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #25: Regulatory Requirements for IND/NDA | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #25: Regulatory Requirements for IND/NDA | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #25: Regulatory Requirements for IND/NDA | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #25: Regulatory Requirements for IND/NDA | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #26: “Has it Happened Already?” | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #26: “Has it Happened Already?” | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #26: “Has it Happened Already?” | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #26: “Has it Happened Already?” | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #28: Leadership: How to Organize and Lead People | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #28: Leadership: How to Organize and Lead People | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #28: Leadership: How to Organize and Lead People | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #28: Leadership: How to Organize and Lead People | Credit TypePMI | Max Credits3.25 | CEU0.000 |
| #28: Leadership: How to Organize and Lead People | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #33: R&D QA Comprehensive Quality Strategy | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #33: R&D QA Comprehensive Quality Strategy | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #33: R&D QA Comprehensive Quality Strategy | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #33: R&D QA Comprehensive Quality Strategy | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #34: Preparing for a US FDA Advisory Committee Mee | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #34: Preparing for a US FDA Advisory Committee Mee | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #34: Preparing for a US FDA Advisory Committee Mee | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #34: Preparing for a US FDA Advisory Committee Mee | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| #35: Japan Regulatory Environment | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| #35: Japan Regulatory Environment | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| #35: Japan Regulatory Environment | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| #35: Japan Regulatory Environment | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| CANCELLED #27: European Regulatory Meetings: How Best to Pre- Cancelled | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
| CANCELLED #27: European Regulatory Meetings: How Best to Pre- Cancelled | Credit TypeCME | Max Credits3.25 | CEU0.000 |
| CANCELLED #27: European Regulatory Meetings: How Best to Pre- Cancelled | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
| CANCELLED #27: European Regulatory Meetings: How Best to Pre- Cancelled | Credit TypeRN | Max Credits3.25 | CEU0.000 |
| DIA 2020 Global Annual Meeting | Credit TypeACPE | Max Credits20.25 | CEU2.025 |
| DIA 2020 Global Annual Meeting | Credit TypeCME | Max Credits20.25 | CEU0.000 |
| DIA 2020 Global Annual Meeting | Credit TypeIACET | Max Credits20.25 | CEU2.000 |
| DIA 2020 Global Annual Meeting | Credit TypePMI | Max Credits4.00 | CEU0.000 |
| DIA 2020 Global Annual Meeting | Credit TypeRN | Max Credits20.25 | CEU0.000 |
Statement of Credit:
If you would like to receive a statement of credit, you must attend the virtual short course, complete the evaluation, and claim credit via the online credit request process through My Transcript. My Transcript will be available for credit requests on Thursday, June 25, 2020.To access My Transcript:
- Visit DIAglobal.org, select “Sign in” and you will be prompted for your user ID and password
- Choose MENU, found in the upper left corner
- Under CONFERENCES select “Continuing Education"
- Select the blue “My Transcript” button followed by “Credit Request” to process your credit request for the short course
Have an account?